Literature DB >> 24288209

Why should regulators consider using patient preferences in benefit-risk assessment?

Janine A van Til1, Maarten J Ijzerman.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24288209     DOI： 10.1007/s40273-013-0118-6

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  19 in total

1.  The importance of quality, access and price to health care consumers in Bulgaria: a self-explicated approach.

Authors:  Milena Pavlova; Wim Groot; Godefridus van Merode
Journal:  Int J Health Plann Manage       Date:  2003 Oct-Dec

2.  A consumer involvement model for health technology assessment in Canada.

Authors:  Jayne Pivik; Elisabeth Rode; Christopher Ward
Journal:  Health Policy       Date:  2004-08       Impact factor: 2.980

3.  Defining patient-reported outcomes.

Authors:  Lynda C Doward; Stephen P McKenna
Journal:  Value Health       Date:  2004 Sep-Oct       Impact factor: 5.725

Review 4.  Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach.

Authors:  S Oliver; L Clarke-Jones; R Rees; R Milne; P Buchanan; J Gabbay; G Gyte; A Oakley; K Stein
Journal:  Health Technol Assess       Date:  2004-04       Impact factor: 4.014

5.  The use of multi-criteria decision analysis weight elicitation techniques in patients with mild cognitive impairment: a pilot study.

Authors:  Janine A van Til; James G Dolan; Anne M Stiggelbout; Karin C G M Groothuis; Maarten J Ijzerman
Journal:  Patient       Date:  2008-04-01       Impact factor: 3.883

Review 6.  Valuing citizen and patient preferences in health: recent developments in three types of best-worst scaling.

Authors:  Terry N Flynn
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2010-06       Impact factor: 2.217

7.  Methodological issues in the application of conjoint analysis in health care.

Authors:  M Ryan; E McIntosh; P Shackley
Journal:  Health Econ       Date:  1998-06       Impact factor: 3.046

8.  Improving health care by understanding patient preferences: the role of computer technology.

Authors:  P F Brennan; I Strombom
Journal:  J Am Med Inform Assoc       Date:  1998 May-Jun       Impact factor: 4.497

9.  Patient preferences.

Authors:  D F Brennan
Journal:  Ann Emerg Med       Date:  1995-08       Impact factor: 5.721

10.  Incorporating patients' preferences into medical decision making.

Authors:  Liana Fraenkel
Journal:  Med Care Res Rev       Date:  2012-11-06       Impact factor: 3.929
View more
  20 in total

1.  Engaging patients and caregivers in prioritizing symptoms impacting quality of life for Duchenne and Becker muscular dystrophy.

Authors:  Ilene L Hollin; Holly Peay; Ryan Fischer; Ellen M Janssen; John F P Bridges
Journal:  Qual Life Res       Date:  2018-05-26       Impact factor: 4.147

2.  Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer.

Authors:  Mattea Reinisch; Norbert Marschner; Thorsten Otto; Agnieszka Korfel; Clemens Stoffregen; Achim Wöckel
Journal:  Breast Care (Basel)       Date:  2021-01-25       Impact factor: 2.860

3.  Outcome Preferences in Patients With Noninfectious Uveitis: Results of a Best-Worst Scaling Study.

Authors:  Tsung Yu; Janet T Holbrook; Jennifer E Thorne; Terry N Flynn; Mark L Van Natta; Milo A Puhan
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-10       Impact factor: 4.799

4.  Estimating the value of medical treatments to patients using probabilistic multi criteria decision analysis.

Authors:  Henk Broekhuizen; Catharina G M Groothuis-Oudshoorn; A Brett Hauber; Jeroen P Jansen; Maarten J IJzerman
Journal:  BMC Med Inform Decis Mak       Date:  2015-12-02       Impact factor: 2.796

5.  Risk Perceptions in Diabetic Patients Who Have Experienced Adverse Events: Implications for Patient Involvement in Regulatory Decisions.

Authors:  Mikkel Lindskov Sachs; Sofia Kälvemark Sporrong; Morten Colding-Jørgensen; Sven Frokjaer; Per Helboe; Katarina Jelic; Susanne Kaae
Journal:  Pharmaceut Med       Date:  2017-07-18

6.  Weighing Clinical Evidence Using Patient Preferences: An Application of Probabilistic Multi-Criteria Decision Analysis.

Authors:  Henk Broekhuizen; Maarten J IJzerman; A Brett Hauber; Catharina G M Groothuis-Oudshoorn
Journal:  Pharmacoeconomics       Date:  2017-03       Impact factor: 4.981

7.  Developing and piloting an instrument to prioritize the worries of patients with acute myeloid leukemia.

Authors:  John Fp Bridges; Allison H Oakes; Crystal A Reinhart; Ernest Voyard; Bernadette O'Donoghue
Journal:  Patient Prefer Adherence       Date:  2018-04-27       Impact factor: 2.711

8.  EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Regulatory Processes.

Authors:  David Haerry; Cordula Landgraf; Kay Warner; Amy Hunter; Ingrid Klingmann; Matthew May; Wolf See
Journal:  Front Med (Lausanne)       Date:  2018-08-17

9.  Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice.

Authors:  Rosanne Janssens; Eline van Overbeeke; Lotte Verswijvel; Lissa Meeusen; Carolien Coenegrachts; Kim Pauwels; Marc Dooms; Hilde Stevens; Steven Simoens; Isabelle Huys
Journal:  Front Med (Lausanne)       Date:  2018-10-11

10.  Patient Perspectives on the Value of Patient Preference Information in Regulatory Decision Making: A Qualitative Study in Swedish Patients with Rheumatoid Arthritis.

Authors:  Karin Schölin Bywall; Jorien Veldwijk; Mats G Hansson; Ulrik Kihlbom
Journal:  Patient       Date:  2019-06       Impact factor: 3.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.